Expert meetings
The Medicines and Medical Devices Agency of Serbia organizes expert meetings in order to provide information to the professional public.
Expert meetings that will be held in the upcoming period can be viewed in the “Announcements of workshops and events,” which is located on the main page of the ALIMS website.
Meetings held in 2013-2018
The symposium was intended for pharmacists working in public and private pharmacies as well as hospital pharmacies. The main topic was information on medicines as an integral part of the National Medicines Policy, indicators for assessment of the rational medicine therapy and data on marketing and consumption of medicines for human and veterinary use. The experiences in approving the advertising of medicines and medical devices were also presented, as well as in assessment of the innovation, pharmacoeconomic parameters and promotional materials of a medicine. The ALIMS integrated information system was presented at the meeting, as well as its publications and website.
The Ministry of Health, in addition to auspices, as on previous occasions, had an active part in the realization of the symposium, and additional support was provided by the Association of the Manufacturers of Innovative Drugs – INOVIA and Association for Advancement of Clinical Research of Serbia – KLINIS.
The main subject of the symposium was clinical trials of medicines and medical devices. A large number of eminent speakers from Serbia and 12 countries in Europe, from Ireland to Turkey, covered all aspects of this field, and also the issues of bioequivalence studies, new aspects of monitoring adverse reactions to medicines and medical devices in Serbia and Europe, networking and practical aspects of e-business in the pharmaceutical field, assessment of pre-clinical and clinical documentation in the licensing process for medicines, data exclusivity, etc. Read more
The first annual QP conference, titled “How to meet challenges for QPs in South East European countries” was held on October 03- 04, 2013 at Danubia Park Hotel, Lake Srebrno Jezero, Veliko Gradiste organized by the Faculty of Pharmacy, University of Belgrade and the Medicines and Medical Devices Agency of Serbia. The goal of the conference was to mark the tremendous progress that has been made in terms of improving the pharmaceutical and, consequently, the healthcare system in Serbia by introducing standards for marketing medicines in the pharmaceutical industry regarding the qualified and responsible persons performing such a difficult and specific job (Qualified Person or QP). The Faculty of Pharmacy, University of Belgrade, introduced specialization in this field, thereby additional impetus to the experts who will be educated for this type of job in the best way and place, and thus acquire the necessary competence and comprehensiveness of knowledge that does not include just one or a couple of areas but also the insight and understanding of pharmaceutical science in general. The meeting gathered all representative stakeholders from the pharmaceutical industry and eminent speakers and participants, and not only from the neighbouring countries, which ensured the opportunity for open dialogue, necessary networking and even closer cooperation.
As a representative of ALIMS, and instead of ALIMS Acting Director Sasa Jacovic, Sp. dr med., who could not attend the meeting, Pavle Zelic, Pharm. B., person in charge of International Cooperation and Public Relations in ALIMS, held a lecture on “The Ambitions and Challenges in the Regulation of Medicines and Medical Devices in Serbia.”
In addition to 150 participants, this high-level meeting also gathered eminent speakers from government institutions and industry in the region and Europe and enabled a dynamic dialogue with representatives of the pharmaceutical industry and healthcare professionals in the pharmaceutical and medical practice, and especially with professional associations. Thus, conclusions were adopted on further steps regarding the control of medicinal products markets and prices, enhanced regional and international cooperation, particularly in the area of safety and quality of medicines, and suggestions for future meetings in order to further promote and implement the initiated areas of cooperation.
